Pro-adrenomedullin as a Prognostic Marker in Neonatal Sepsis

Zekai Tahir Burak Maternity Teaching Hospital Neonatal Intensive Care Unit

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01362504

Enrollment

Registered

2011-05-30

Start date

2011-05-31

Completion date

2011-09-30

Last updated

2011-10-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sepsis

Keywords

Pro-adrenomedullin, Neonatal sepsis, Prognosis, Sepsis marker, Clinical sepsis, Proven sepsis

Brief summary

The aim of this study was to clarify the prognostic value of serum pro-Adrenomedullin level in neonatal sepsis. Eighty term and preterm neonates with sepsis were enrolled in this study. Eighty healthy matched neonates served as a control group.

Interventions

None listed

Study design

Observational model

CASE_CONTROL

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

24 Weeks to 42 Weeks

Healthy volunteers

Yes

Inclusion criteria

* Clinical sepsis and/or proven sepsis.

Exclusion criteria

* Acute kidney injury * Intracranial hemorrhage (Grade III and IV)

Countries

Turkey (Türkiye)

Outcome results